Monday, September 27, 2021


Covaxin expected to receive WHO’s approval this week

In June, WHO had accepted Bharat Biotech's EOI i.e. Expression of Interest for its approval.

DCGI accepts study proposal on mixing of Covishield and Covaxin vaccines

The trials will be conducted on 300 healthy volunteers.

Covaxin effective against delta plus variant of COVID-19: ICMR Study

Experts have speculated that the Delta Plus variant may be responsible for the third wave of COVID-19.

Covaxin trial results on children to be released by September

COVID-19 vaccine trials for children is being rapidly conducted in the country.

Bharat Biotech’s Covaxin likely to get WHO’s approval soon

WHO Chief Scientist Dr. Soumya Swaminathan said that the data of Covaxin trial "looks good".

Covaxin found to be 77.8% effective in the third phase trial

Covaxin has been found to be 65% effective against the delta variant of the COVID-19.

Bharat Biotech likely to have pre-submission meeting with WHO today for Covaxin

Covaxin has been found to be 77.8% effective in the third phase trial.

Health Ministry: Covishield and Covaxin are effective against delta variant of COVID-19

22 cases of delta plus variant of COVID-19 have been found in India.

Covaxin found 77.8% effective in the third phase trial

The third phase trial of Covaxin was conducted on 25,800 people.

Most Read